Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: Impact of triggering disease and early treatment with etoposide

British Journal of Haematology

Volumn 168, Issue 1, 2015, Pages 63-68

  Arca, Marc ^a   Fardet, Laurence ^b,c   Galicier, Lionel ^d   Rivière, Sébastien ^b,c   Marzac, Christophe ^c   Aumont, Cédric ^e   Lambotte, Olivier ^e,f   Coppo, Paul ^b,c,g,h  

^a Service d'Hematologie   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e BICÊTRE HOSPITAL   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g Ctr Natl de Ref des Antibiot   (France)

^h INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Etoposide; Haemophagocytic syndrome; Human immunodeficiency virus infection; Lymphoma; Prognostic factor

Indexed keywords

ASPARTATE AMINOTRANSFERASE; ETOPOSIDE; GLUCOCORTICOID; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; ANTINEOPLASTIC AGENT;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMOPHAGOCYTIC SYNDROME; HODGKIN DISEASE; HUMAN; INFECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TEACHING HOSPITAL; TERTIARY HEALTH CARE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; OUTCOME ASSESSMENT; RISK;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ETOPOSIDE; FEMALE; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84915731934     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13102     Document Type: Article

References (28)

1. Barta, S.K., Xue, X., Wang, D., Tamari, R., Lee, J.Y., Mounier, N., Kaplan, L.D., Ribera, J.M., Spina, M., Tirelli, U., Weiss, R., Galicier, L., Boue, F., Wilson, W.H., Wyen, C., Oriol, A., Navarro, J.T., Dunleavy, K., Little, R.F., Ratner, L., Garcia, O., Morgades, M., Remick, S.C., Noy, A. & Sparano, J.A. (2013) Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood, 122, 3251-3262.
2. Bourquelot, P., Oksenhendler, E., Wolff, M., Fegueux, S., Piketty, C., D'Agay, M.F. & Clauvel, J.P. (1993) Hemophagocytic syndrome in HIV infection. Presse Medicale (Paris, France: 1983), 22, 1217-1220.
3. Buyse, S., Teixeira, L., Galicier, L., Mariotte, E., Lemiale, V., Seguin, A., Bertheau, P., Canet, E., de Labarthe, A., Darmon, M., Rybojad, M., Schlemmer, B. & Azoulay, E. (2010) Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Medicine, 36, 1695-1702.
4. Chang, C.S., Wang, C.H., Su, I.J., Chen, Y.C. & Shen, M.C. (1994) Hematophagic histiocytosis: a clinicopathologic analysis of 23 cases with special reference to the association with peripheral T-cell lymphoma. Journal of the Formosan Medical Association, 93, 421-428.
5. Clementi, R., Locatelli, F., Dupre, L., Garaventa, A., Emmi, L., Bregni, M., Cefalo, G., Moretta, A., Danesino, C., Comis, M., Pession, A., Ramenghi, U., Maccario, R., Arico, M. & Roncarolo, M.G. (2005) A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood, 105, 4424-4428.
6. Creput, C., Galicier, L., Buyse, S. & Azoulay, E. (2008) Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Medicine, 34, 1177-1187.
7. Dhote, R., Simon, J., Papo, T., Detournay, B., Sailler, L., Andre, M.H., Dupond, J.L., Larroche, C., Piette, A.M., Mechenstock, D., Ziza, J.M., Arlaud, J., Labussiere, A.S., Desvaux, A., Baty, V., Blanche, P., Schaeffer, A., Piette, J.C., Guillevin, L., Boissonnas, A. & Christoforov, B. (2003) Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis and Rheumatism, 49, 633-639.
8. Fardet, L., Lambotte, O., Meynard, J.L., Kamouh, W., Galicier, L., Marzac, C., de Labarthe, A., Cabane, J., Lebbe, C., Coppo, P., Molina, J.M. & Martinez, V. (2010) Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis. AIDS, 24, 1299-1306.
9. Fardet, L., Galicier, L., Lambotte, O., Marzac, C., Aumont, C., Chahwan, D., Coppo, P. & Hejblum, G. (2014) Development and validation of a score for the diagnosis of reactive hemophagocytic syndrome (HScore). Arthritis & Rheumatology, doi: 10.1002/art.38690.
10. Fukaya, S., Yasuda, S., Hashimoto, T., Oku, K., Kataoka, H., Horita, T., Atsumi, T. & Koike, T. (2008) Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford), 47, 1686-1691.
11. Gerard, L., Berezne, A., Galicier, L., Meignin, V., Obadia, M., De Castro, N., Jacomet, C., Verdon, R., Madelaine-Chambrin, I., Boulanger, E., Chevret, S., Agbalika, F. & Oksenhendler, E. (2007) Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial. Journal of Clinical Oncology, 25, 3350-3356.
12. Gerard, L., Michot, J.M., Burcheri, S., Fieschi, C., Longuet, P., Delcey, V., Meignin, V., Agbalika, F., Chevret, S., Oksenhendler, E. & Galicier, L. (2012) Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease. Blood, 119, 2228-2233.
13. Grateau, G., Bachmeyer, C., Blanche, P., Jouanne, M., Tulliez, M., Galland, C., Sicard, D. & Sereni, D. (1997) Haemophagocytic syndrome in patients infected with the human immunodeficiency virus: nine cases and a review. Journal of Infection, 34, 219-225.
14. Henter, J.I., Horne, A., Arico, M., Egeler, R.M., Filipovich, A.H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J. & Janka, G. (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 48, 124-131.
15. Imashuku, S., Kuriyama, K., Teramura, T., Ishii, E., Kinugawa, N., Kato, M., Sako, M. & Hibi, S. (2001) Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Journal of Clinical Oncology, 19, 2665-2673.
16. Johnson, T.S., Terrell, C.E., Millen, S.H., Katz, J.D., Hildeman, D.A. & Jordan, M.B. (2014) Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. The Journal of Immunology, 192, 84-91.
17. Kaito, K., Kobayashi, M., Katayama, T., Otsubo, H., Ogasawara, Y., Sekita, T., Saeki, A., Sakamoto, M., Nishiwaki, K., Masuoka, H., Shimada, T., Yoshida, M. & Hosoya, T. (1997) Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. European Journal of Haematology, 59, 247-253.
18. Li, J., Wang, Q., Zheng, W., Ma, J., Zhang, W., Wang, W. & Tian, X. (2014) Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine, 93, 100-105.
19. Oksenhendler, E. (2009) HIV-associated multicentric Castleman disease. Current Opinion in HIV and AIDS, 4, 16-21.
20. Pachlopnik Schmid, J., Cote, M., Menager, M.M., Burgess, A., Nehme, N., Menasche, G., Fischer, A. & de Saint Basile, G. (2010) Inherited defects in lymphocyte cytotoxic activity. Immunological Reviews, 235, 10-23.
21. Riviere, S., Galicier, L., Coppo, P., Marzac, C., Aumont, C., Lambotte, O. & Fardet, L. (2014) Reactive hemophagocytic syndrome in adults: a multicenter retrospective analysis of 162 patients. American Journal of Medicine, doi: 10.1016/j.amjmed.2014.04.034.
22. Rouphael, N.G., Talati, N.J., Vaughan, C., Cunningham, K., Moreira, R. & Gould, C. (2007) Infections associated with haemophagocytic syndrome. The Lancet Infectious Diseases, 7, 814-822.
23. Takahashi, N., Miura, I., Chubachi, A., Miura, A.B. & Nakamura, S. (2001) A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. International Journal of Hematology, 74, 303-308.
24. Tiab, M., Mechinaud, F., Hamidou, M., Gaillard, F., Raffi, F. & Harousseau, J.L. (1996) Hemophagocytic syndromes. A series of 23 cases. Annales de Medecine Interne (Paris), 147, 138-144.
25. Tseng, Y.T., Sheng, W.H., Lin, B.H., Lin, C.W., Wang, J.T., Chen, Y.C. & Chang, S.C. (2011) Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. Journal of Microbiology, Immunology, and Infection, 44, 191-197.
26. Veerakul, G., Sanpakit, K., Tanphaichitr, V.S., Mahasandana, C. & Jirarattanasopa, N. (2002) Secondary hemophagocytic lymphohistiocytosis in children: an analysis of etiology and outcome. Journal of the Medical Association of Thailand, 85, S530-S541.
27. Wong, K.F. & Chan, J.K. (1992) Reactive hemophagocytic syndrome-a clinicopathologic study of 40 patients in an Oriental population. American Journal of Medicine, 93, 177-180.
28. Zhang, K., Jordan, M.B., Marsh, R.A., Johnson, J.A., Kissell, D., Meller, J., Villanueva, J., Risma, K.A., Wei, Q., Klein, P.S. & Filipovich, A.H. (2011) Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood, 118, 5794-5798.